No prior authorization
Does Wellpoint Insurance Company require prior authorization for Cimduo?
Wellpoint Insurance Company does not require prior authorization for Cimduo on the Medicare Part D plans that cover it.
No covering plan from this payer files a prior-authorization requirement for this drug.
By product strength
| RxNorm product | Plans covering | Require prior auth | Status |
|---|---|---|---|
| lamivudine 300 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Cimduo]2003255 | 14 / 14 | 0 | No prior authorization |
Product names come from RxNorm (U.S. National Library of Medicine).
Source
Monthly Prescription Drug Plan Formulary and Pharmacy Network Information — Basic Drugs Formulary File- Effective
- 2026-06-30
- Retrieved
- 2026-07-19
- SHA-256
- e626e6bcda1aa6a0071e6f0df6bafe686ae41842cdf0a9feffdc649b6d3ff3ae
We publish the hash of the exact file we ingested so any answer can be audited against the bytes CMS served that day.
Cimduo at other payers
Administrative information only. Benefily reports what a payer has published in its own prior-authorization policy as of the effective date shown. It is not medical advice, not a coverage or payment guarantee, and not an authorization. Requirements vary by plan, place of service and member benefits — always verify with the payer before rendering service.